Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.53 USD | +1.29% | -5.72% | +4.16% |
04-01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
04-01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
Business Summary
Number of employees: 145
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 16 | 100.0 % | 17 | 100.0 % | +9.75% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 17 | 100.0 % | +9.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Roger Jeffs
CEO | Chief Executive Officer | 62 | 17/11/20 |
Michael Kaseta
DFI | Director of Finance/CFO | 48 | 29/11/20 |
Rajeev Saggar
CTO | Chief Tech/Sci/R&D Officer | 50 | 17/07/22 |
Damian deGoa
BRD | Director/Board Member | 45 | 13/12/20 |
Scott Moomaw
PRN | Corporate Officer/Principal | 54 | 17/11/20 |
General Counsel | 49 | 28/02/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Kirsch
BRD | Director/Board Member | 72 | 27/06/20 |
Joanna Horobin
BRD | Director/Board Member | 69 | 27/06/20 |
Roger Jeffs
CEO | Chief Executive Officer | 62 | 17/11/20 |
Stephen Bloch
CHM | Chairman | 62 | 27/06/20 |
Paul Manning
BRD | Director/Board Member | 68 | 17/11/20 |
Raman Singh
BRD | Director/Board Member | 53 | 27/06/20 |
David Johnson
BRD | Director/Board Member | 41 | 12/04/21 |
Director/Board Member | 61 | 27/06/20 | |
Damian deGoa
BRD | Director/Board Member | 45 | 13/12/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,027,776 | 66,601,010 ( 87.60 %) | 0 | 87.60 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.16% | 953M | |
+25.83% | 661B | |
+26.16% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.64% | 231B | |
+5.33% | 200B | |
-9.00% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- LQDA Stock
- Company Liquidia Corporation